Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2014

01.12.2014 | Research Article

Medication use review in Qatar: Are community pharmacists prepared for the extended professional role?

verfasst von: Ahmed Hussein Babiker, Louise Carson, Ahmed Awaisu

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background The incidence of chronic illnesses is increasing globally. Non-adherence to medications and other medication-related problems are common among patients receiving long-term medications. Medication use review (MUR) is a service provision with an accredited pharmacist undertaking structured, adherence-centered reviews with patients receiving multiple medications. MUR services are not yet available in community pharmacies in Qatar. Objective The current study aims to evaluate community pharmacists’ knowledge, attitudes, and perception towards establishing MUR as an extended role in patient care. Setting Private community pharmacies in Qatar including chains and independent pharmacies. Methodology A cross-sectional survey using a self-administered questionnaire was conducted among licensed community pharmacists from December 2012 to January 2013. Data analysis was conducted using descriptive and inferential statistics. Main outcome measures Knowledge, attitudes, and practices related to MUR concept and services. Results A total of 123 participants responded to the survey (response rate 56 %). The mean total knowledge score was 71.4 ± 14.7 %. An overwhelming proportion of the participants (97 %) were able to identify the scope of MUR in relation to chronic illnesses and at enhancing the quality of pharmaceutical care. Furthermore, 80 % of the respondents were able to identify patients of priority for inclusion in an MUR program. However, only 43 % of the participants knew that acute medical conditions were not the principal focus of an MUR service, while at least 97 % acknowledged that the provision of MUR services is a great opportunity for an extended role of community pharmacists and that MUR makes excellent use of the pharmacist’s professional skills in the community. The participants generally reported concerns about time, dedicated consultation area, and support staff as significant barriers towards MUR implementation. Conclusion This study suggests that community pharmacists in Qatar had sufficient knowledge about the concept of MUR and its scope, but there were still important deficiencies that warrant further education. The findings have important implications on policy and practice pertaining to the implementation of MUR as an extended role of pharmacists and as part of Qatar’s National Health Strategy to move primary health care forward.
Literatur
1.
Zurück zum Zitat Heneghan C, Blacklock C, Perera R, Davis R, Banerjee A, Gill P, et al. Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open. 2013;3:e003298.PubMedCentralPubMedCrossRef Heneghan C, Blacklock C, Perera R, Davis R, Banerjee A, Gill P, et al. Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open. 2013;3:e003298.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Soc Adm Pharm. 2013;9:817–27.CrossRef Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Soc Adm Pharm. 2013;9:817–27.CrossRef
3.
Zurück zum Zitat Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58–66. Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58–66.
7.
Zurück zum Zitat Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:526–35.CrossRef Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:526–35.CrossRef
8.
Zurück zum Zitat Livingstone C. Onwards and upwards with target MURs. Pharm J. 2010;284:57–60. Livingstone C. Onwards and upwards with target MURs. Pharm J. 2010;284:57–60.
10.
Zurück zum Zitat Latif A, Pollock K, Boardman HF. The contribution of the medicines use review (MUR) consultation to counselling practice in community pharmacies. Patient Educ Couns. 2011;83:336–44.PubMedCentralPubMedCrossRef Latif A, Pollock K, Boardman HF. The contribution of the medicines use review (MUR) consultation to counselling practice in community pharmacies. Patient Educ Couns. 2011;83:336–44.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat DaVanzo J, Dobson A, Koeni L, Book R. Medication therapy management services: a Critical Review. J Am Pharm Assoc. 2005;45:580–7.CrossRef DaVanzo J, Dobson A, Koeni L, Book R. Medication therapy management services: a Critical Review. J Am Pharm Assoc. 2005;45:580–7.CrossRef
14.
Zurück zum Zitat Thompson CA. State-paid medication therapy management services succeed. Am J Health Syst Pharm. 2008;65:490–8.PubMedCrossRef Thompson CA. State-paid medication therapy management services succeed. Am J Health Syst Pharm. 2008;65:490–8.PubMedCrossRef
15.
Zurück zum Zitat Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009;122:26–35. Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009;122:26–35.
16.
Zurück zum Zitat Kheir N, Fahey M. Pharmacy practice in Qatar: challenges and opportunities. South Med Rev. 2011;4:45–9.CrossRef Kheir N, Fahey M. Pharmacy practice in Qatar: challenges and opportunities. South Med Rev. 2011;4:45–9.CrossRef
17.
Zurück zum Zitat Zaidan M, Singh R, Wazaify M, Tahaineh L. Physicians’ perceptions, expectations, and experience with pharmacists at Hamad Medical Corporation in Qatar. J Multidiscip Healthc. 2011;4:85–90.PubMedCentralPubMedCrossRef Zaidan M, Singh R, Wazaify M, Tahaineh L. Physicians’ perceptions, expectations, and experience with pharmacists at Hamad Medical Corporation in Qatar. J Multidiscip Healthc. 2011;4:85–90.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson P. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72:133.PubMedCentralPubMedCrossRef Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson P. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72:133.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.PubMedCentralPubMedCrossRef El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943–55.PubMedCrossRef Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943–55.PubMedCrossRef
27.
Zurück zum Zitat Hatah E, Braund R, Duffull S, Tordoff J. General practitioners’ perceptions of pharmacists’ new services in New Zealand. Int J Clin Pharm. 2012;34:364–73.PubMedCrossRef Hatah E, Braund R, Duffull S, Tordoff J. General practitioners’ perceptions of pharmacists’ new services in New Zealand. Int J Clin Pharm. 2012;34:364–73.PubMedCrossRef
30.
Zurück zum Zitat Hassell K, Seston EM, Schafheutle EI, Wagner A, Eden M. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review of the evidence. Health Soc Care Community. 2011;19(6):561–75.PubMedCrossRef Hassell K, Seston EM, Schafheutle EI, Wagner A, Eden M. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review of the evidence. Health Soc Care Community. 2011;19(6):561–75.PubMedCrossRef
31.
Zurück zum Zitat Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.PubMedCentralPubMedCrossRef Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.PubMedCentralPubMedCrossRef
Metadaten
Titel
Medication use review in Qatar: Are community pharmacists prepared for the extended professional role?
verfasst von
Ahmed Hussein Babiker
Louise Carson
Ahmed Awaisu
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2014
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-0025-8

Weitere Artikel der Ausgabe 6/2014

International Journal of Clinical Pharmacy 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.